KP

Krishna Pratap Ravindranathan

Active Director Managing Director DIN 07270170
DIN 07270170 First appointment Feb 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishna Pratap Ravindranathan

Data last updated:

Krishna Pratap Ravindranathan is a Managing Director at Genomic Shield Diagnostics Private Limited (since 2016). The company operates in Healthcare.

DIN 07270170
Primary Designation Managing Director
Industry Healthcare
First Appointment 18 Feb 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director18 Feb 20162016Active

Board colleagues of Krishna Pratap Ravindranathan

Directorship timeline

Open interactive timeline →
Genomic Shield Diagnostics Private Limited
Premium access

Shareholding and investment profile for Krishna Pratap Ravindranathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Pratap Ravindranathan

Krishna Pratap Ravindranathan currently holds 1 directorship: Genomic Shield Diagnostics Private Limited (Managing Director, since 18 Feb 2016).

Krishna Pratap Ravindranathan was first appointed on 18 Feb 2016 as Managing Director at Genomic Shield Diagnostics Private Limited.

The current boards of Krishna Pratap Ravindranathan's companies include Geetha Ravindranathan (Genomic Shield Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available